Top Tweets for #StopDAPT2
#TCT2025 Presentation is over, really relieved..☕
Meeting researchers around the world who are engaged in the area I also worked in is an exciting thing.
We appreciate the co-investigators and participants of #STOPDAPT2 and #STOPDAPT2ACS. Wait a moment for publication!
Neste bate-papo com especialistas, do #3i, os Drs. @LuhandaM, @Roggg8 e Carlos Campos apresentam os destaques do Estudo #StopDapt2 e a repercussão da #shortdapt com clopidogrel na prática.
Confira o conteúdo completo no site: https://t.co/LYQOXdUTAv
#Clopidogrel monotherapy following 1-month #DAPT is associated with numerically lower rate of composite CV outcomes and significantly ⬇️ CV events compared with #aspirin monotherapy following 12-month DAPT. https://t.co/crqKiPgORo
#JACC #PCI #STOPDAPT2 #cardiology #CardioTwitter
#Clopidogrel monotherapy following 1-month #DAPT is associated with numerically lower rate of composite CV outcomes and significantly ⬇️ CV events compared with #aspirin monotherapy following 12-month DAPT. https://t.co/cdbxy1PT4Z
#JACC #PCI #STOPDAPT2 @HirotWatanabeMD
Very proud to announce the 5-year results of the #STOPDAPT2 in a worldlink forum in #TCT2023 with a full audience
Clopidogrel versus Aspirin Monotherapy Beyond 1 Year After PCI: STOPDAPT-2 5-Year Results | Journal of the American College of Cardiology https://t.co/acQPJZue2X
@danmckenzie73 @HirotWatanabeMD @ncurzen Utilization of #IVUS in #STOPDAPT2 was 97.3% https://t.co/W1zT8zJ039
Yet keep in mind 🧠 #STOPDAPT2 #ACS trial https://t.co/1x6Dqb6jQt In patients with ACS with successful #PCI, #clopidogrel monotherapy after 1 to 2 months of #DAPT failed to attest #noninferiority to standard 12 months of DAPT for the net clinical benefit #CardioTwitter
#STOPDAPT2 Total Cohort: Clopidogrel monotherapy after 1mo #DAPT vs 12mo DAPT with #aspirin and #clopidogrel benefits in ⬇️ major bleeding without ⬆️ in CV events https://t.co/50bAjvHaGY @DFCapodanno @vlgmrc @Drroxmehran @DLBHATTMD @mmamas1973 @HirotWatanabeMD @CMichaelGibson
https://t.co/WlcFnza0dQ
#TCROSSNEWS interviewed Dr. Watanabe of Kyoto University on the optimal #DAPT period for #ACS patients based on the #STOPDAPT2 study
While 1-month DAPT reduced bleeding events compared to 12-month, there was a trend towards increased #Cardiovascular events
My coverage of #MASTERDAPT and the #STOPDAPT2 total cohort at #TCT2021. Memorable quote prize in this story goes to @ajaykirtane: “It's not just only about the stent.”
https://t.co/o6iwEXR82A
@djc795 @hvanspall @mmamas1973 @vlgmrc @ShelleyWood2 @ShehabAnwer @iamritu @purviparwani @alaide_chief @LAzzaliniMD @AntoniousAttall @SilCastelletti @SimoneBiscaglia @agtruesdell @tristonsmithmd @evandrofilhobr @DrAsifQasim @Uqayyum123 Fully agree. And at least for ACS, #STOPDAPT2 is catching that non-inferiority pendulum before it swings too far.
Glad that at least with combining trials we get some more sound data than in #WOEST hinting at the tricky longlasting stickiness of activated thrombocytes
#ESCCongress my @TCTMD interview with @HirotWatanabeMD for STOPDAPT-2 ACS ➡️ https://t.co/v7asfy7lZS when do the ischemic events occur in relation to stopping aspirin? @DFCapodanno @djc795 @ShelleyWood2 @mirvatalasnag @jgranadacrf @GreggWStone @HanCardiomd @aayshacader @ncurzen
One-month #DAPT provided significant reduction of major bleeding without any increase of #CV events over 12-month DAPT in high bleeding risk patients, although the analysis was underpowered #STOPDAPT2 #AHAJournals https://t.co/O5BMsxu2j7 @HirotWatanabeMD
🚨New STOPDAPT2 HBR analysis is coming 🚨
You’ve already seen superior safety with #XIENCE, but we’ll be sharing new findings on #STOPDAPT2 focused on HBR patients at #TCT2019. Stay tuned for more.
https://t.co/SuqoynWiDy
Important Safety Info: https://t.co/h3CVEAZMmG
#Xience #STOPDAPT2 #Abbott #safetyfirst for your patients #DES #goldstandard
https://t.co/aWZywj6TK0
@mmamas1973 @bogdienache @GiuseppeGalati_ @ShelleyZieroth @Dr_Manito Noninferiority of short-course DAPT in #STOPDAPT2 driven by⬇️bleeding, highlighting that bleeding is a more common problem than ischemia in era of DES (perhaps use of IVUS for stent placement a caveat). Super interesting study design & findings.. has it changed your practice?
#STOPDAPT2 on @2minmed via @JAMA_current: 1 month of DAPT followed by clopidogrel monotherapy is both non-inferior and superior to prolonged 12-month DAPT post-PCI with DES, with significantly lower rates of composite cardiovascular and bleeding events.
https://t.co/favWrZ5YfX
We're taking a break this week, fresh Scope next Friday AM! However! Much anticipated from #ACC19, #STOPDAPT2 and #SMARTCHOICE trials now out from @JAMA_current further questioning length of #DAPT after #PCI. Gleefully awaiting the arguments at cards conference like:
“DAPT: The Clinical Duel over Duration” is our next @AbbottCardio #CoRe educational Webex topic on 23rd July 5pm Chaired by @rstables. @NickCurzen will present #STOPDAPT2 data and Dr.A.Lucking to review current research in this area that affects clinical practice. Link 👇🏻
(JAMA) A vueltas con la duración óptima de la doble antiagregación en pac sometidos a ICP https://t.co/i6V0BRgpRS ECA #STOPDAPT2 https://t.co/xIV3L3LJ3H ECA #SMARTCHOICE https://t.co/mJBtJX2ZJn Comentario
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.2M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.2M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers